Medical and tech companies may be better positioned to weather the economic effects of the coronavirus, especially if they’re involved in drug development or treatment.
Unlike most stocks, the Moderna share price has increased during the pandemic, and buying Moderna shares may be seen as a good move by investors. Moderna, Inc (NASDAQ: MRNA) is a biotech company based in Cambridge, Massachusetts that specialises in drug development and drug discovery.
How to buy shares in Moderna
- Compare share trading platforms. To buy shares in a US company you’ll need to find a trading platform that offers access to US stock markets. If you’re just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, including your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Moderna. Find the company by name or ticker symbol: MRNA. Research its history to confirm it’s a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until MRNA reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide how many to buy. Look at today’s price and weigh your budget against a diversified portfolio that can minimise risk through the market’s ups and downs. You may be able to buy a fractional share (for example half of a share) of MRNA depending on your broker.
- Check in on your investment. Congratulations, you own a part of MRNA. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Compare share trading accounts to buy Moderna shares
Should I buy MRNA stock?
Technical analysis is used in finance to forecast the direction of prices by studying the past movements of markets. This is not a recommendation, it represents an analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
About Moderna Inc.
Moderna, Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and autoimmune and cardiovascular diseases. As of February 14, 2020, the company had 12 programs in clinical trials and a total of 24 development candidates in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted and cell surface therapeutics, and systemic intracellular therapeutics. It has strategic alliances with AstraZeneca, Merck & Co., Vertex Pharmaceuticals, Biomedical Advanced Research and Development Authority, Defense Advanced Research Projects Agency, and Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Important: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.